Estudos clínicos
Comprometida em apoiar novos desenvolvimentos em cardiologia, a BIOTRONIK está profundamente envolvida na condução de ensaios clínicos.
As nossas atividades científicas abrangem uma variedade de tópicos na área de gerenciamento do ritmo cardíaco e intervenção cardiovascular.
Em colaboração com especialistas médicos internacionais, buscamos melhorar, continuamente, o diagnóstico e o tratamento de doenças cardíacas e vasculares.
Os bancos de dados abaixo fornecem uma visão geral dos estudos da BIOTRONIK sobre gerenciamento do ritmo cardíaco e intervenção cardiovascular, juntamente com publicações e recursos relacionados.
Filter Clinical Studies
4EVER
Physician-initiated trial investigating the safety of the full 4F endovascular treatment approach of infra-inguinal arterial stenotic disease
At-Home
Remote Management of Pacemaker Patients with Biennial In-clinic evaluation: Continuous Home Monitoring in the Japanese at Home Study. A Randomized Clinical Trial
Watanabe E ET AL., CIRCEP 2020 May;13(5):e007734
doi: 10.1161/CIRCEP.119.007734
BERN
Evaluate long segment (> 120 mm) complex femoro-popliteal disease with Pulsar stent stratified for Critical Limb Ischaemia vs. Intermittent Claudication
BIO-RESORT
Comparison of biodegradable polymer and durable polymer drug-eluting stents in an all comers population
BIO4AMB
Comparing the use of 4F- versus 6F-compatible devices for ambulatory peripheral vascular interventions
BIOFLEX PEACE
Evaluating the safety and efficacy of the Pulsar-18 self-expanding stent for femoropopliteal lesions with optional drug-coated balloon angioplasty in a real-world, all-comers population
BIOFLEX-COF
Investigating the influence of high versus low chronic outward force self-expanding nitinol stents in femoropopliteal occlusive arterial lesions
BIOFLEX-I
Prospective, international, multi-center, investigational device exemption trial evaluating BIOTRONIK Astron nitinol self-expanding stent for iliac arteries
BIOFLOW-I
First-in-man experience with a drug-eluting stent in de novo coronary artery lesions
BIOFLOW-II
Study of the Orsiro Drug Eluting Stent System
BIOFLOW-III
Investigating Orsiro drug-eluting coronary stent
BIOFLOW-V
Randomized Clinical Trial Comparing Orsiro1 Drug-Eluting Stent with Xience2 DES
BIOLUX 4EVER
Evaluating outcomes after treating stenotic or occluded femoropopliteal lesions with the Passeo-18 Lux DCB followed by Pulsar-18 BMS
BIOLUX AV
Assessing the safety and efficacy of paclitaxel-eluting balloon angioplasty for dysfunctional hemodialysis access
BIOLUX P-I
Clinical trial to assess the safety and performance of the coated Passeo-18 Lux paclitaxel-releasing PTA balloon catheter versus the uncoated Passeo-18 balloon catheter for treatment of stenosis of the femoropopliteal arteries
BIOLUX P-I/P-II/P-III Safety Analysis
To collect long-term clinical data on patients treated with either Passeo-18 PTA or Passeo-18 Lux DCB
BIOLUX P-II
First-in-human study to assess the safety and performance of the Passeo-18 Lux drug-coated balloon vs. the uncoated Passeo-18 balloon catheter in patients with stenosis and occlusion of the infrapopliteal arteries
BIOLUX P-III
Investigating safety and efficacy of Passeo-18 Lux in an all-comers real-world population with up to Rutherford 6 disease in the infrainguinal arteries
BIOLUX P-III BENELUX
Investigating the safety and efficacy of Passeo-18 Lux DCB for the treatment of isolated popliteal artery lesions
BIOLUX P-IV CHN
Investigating the safety and efficacy of Passeo-18 Lux DCB for the treatment of isolated popliteal artery lesions
BIOMAG-I
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study
BIOMONITOR III Pooled Analysis
New Generation Miniaturized Insertable Cardiac Monitor with a Long Sensing Vector: Insertion Procedure, Sensing Performance, and Home Monitoring Transmission Success in a Real-World Population
Deneke T et al., Heart Rhythm O2, 2022
BIONETIC-I
Evaluating safety and effectiveness of Dynetic-35 balloon-expandable stent for the treatment of atherosclerotic disease in the iliac arteries
BIONETIC-I TRA
Evaluating the safety and feasibility of using the Dynetic-35 stent via a transradial approach to treat iliac artery lesions